Pyruvate dehydrogenase E2 deficiency
General Information (adopted from Orphanet):
Synonyms, Signs: |
PDHDD Dihydrolipoyllysine-residue acetyltransferase component of pyruvate dehydrogenase complex deficiency Dihydrolipoamide acetyltransferase component of pyruvate dehydrogenase complex deficiency Lactic acidemia due to defect of E2 lipoyl transacetylase of the pyruvate dehydrogenase complex Pyruvate dehydrogenase complex component E2 deficiency |
Number of Symptoms | 33 |
OrphanetNr: | 79244 |
OMIM Id: |
245348
|
ICD-10: |
E74.4 |
UMLs: |
|
MeSH: |
|
MedDRA: |
|
Snomed: |
|
Prevalence, inheritance and age of onset:
Prevalence: | No data available. |
Inheritance: |
Autosomal recessive Monogenic 16049940 [IBIS] |
Age of onset: |
Infancy Childhood 16049940 [IBIS] |
Disease classification (adopted from Orphanet):
Parent Diseases: |
Pyruvate dehydrogenase deficiency
-Rare developmental defect during embryogenesis -Rare genetic disease -Rare neurologic disease |
Comment:
Pyruvate dehydrogenase (PDH) is a multienzyme complex that catalyses the oxidative decarboxylation of pyruvate to yield acetyl CoA. This is an irreversible reaction that links the pathway of glycolysis in the cytoplasm and the citric acid cycle in the mitochondrion. The enzyme is particularly important in the brain in which, under normal conditions, essentially all of the energy is derived from aerobic glucose oxidation. The complex comprises three catalytic components, PDH (E1), dihydrolipoamide acetyltransferase (E2) and dihydrolipoamide dehydrogenase (E3), and two regulatory components, E1 kinase and phospho-E1-phosphatase, together with a sixth component, E3-binding protein, which is believed to play a role in the attachment of E3 to the E2 core (PMID:15138885). Head et al. (2005) describe two unrelated patients with pyruvate dehydrogenase deficiency caused by defects in the E2 (= DLTA, PDC-E2, PDCE2) subunit. Both patients are less severely affected than typical patients with E1alpha mutations (PMID:16049940). |
Symptom Information:
|
(HPO:0007738) | Uncontrolled eye movements | 16049940 | IBIS | 3 / 7739 | ||
|
(HPO:0000570) | Abnormality of saccadic eye movements | 16049940 | IBIS | 12 / 7739 | ||
|
(HPO:0000639) | Nystagmus | 16049940 | IBIS | 555 / 7739 | ||
|
(HPO:0000657) | Oculomotor apraxia | 16049940 | IBIS | 54 / 7739 | ||
|
(HPO:0000486) | Strabismus | 16049940 | IBIS | 576 / 7739 | ||
|
(HPO:0000508) | Ptosis | 16049940 | IBIS | 459 / 7739 | ||
|
(HPO:0003128) | Lactic acidosis | 16049940 | IBIS | 116 / 7739 | ||
|
(HPO:0004900) | Severe lactic acidosis | 16049940 | IBIS | 5 / 7739 | ||
|
(HPO:0002928) | Decreased activity of the pyruvate dehydrogenase complex | Very frequent [IBIS] | 16049940 | IBIS | 10 / 7739 | |
|
(HPO:0001266) | Choreoathetosis | 16049940 | IBIS | 57 / 7739 | ||
|
(HPO:0003552) | Muscle stiffness | 16049940 | IBIS | 23 / 7739 | ||
|
(HPO:0001251) | Ataxia | 16049940 | IBIS | 413 / 7739 | ||
|
(HPO:0002311) | Incoordination | 16049940 | IBIS | 84 / 7739 | ||
|
(HPO:0001347) | Hyperreflexia | 16049940 | IBIS | 363 / 7739 | ||
|
(HPO:0001348) | Brisk reflexes | 16049940 | IBIS | 15 / 7739 | ||
|
(HPO:0006801) | Hyperactive deep tendon reflexes | 16049940 | IBIS | 21 / 7739 | ||
|
(HPO:0001332) | Dystonia | 16049940 | IBIS | 197 / 7739 | ||
|
(HPO:0007325) | Generalized dystonia | 16049940 | IBIS | 7 / 7739 | ||
|
(HPO:0002268) | Paroxysmal dystonia | 16049940 | IBIS | 11 / 7739 | ||
|
(HPO:0001263) | Global developmental delay | 16049940 | IBIS | 853 / 7739 | ||
|
(HPO:0010862) | Delayed fine motor development | 16049940 | IBIS | 3 / 7739 | ||
|
(HPO:0002194) | Delayed gross motor development | 16049940 | IBIS | 37 / 7739 | ||
|
(HPO:0002307) | Drooling | 16049940 | IBIS | 43 / 7739 | ||
|
(HPO:0002465) | Poor speech | 16049940 | IBIS | 31 / 7739 | ||
|
(HPO:0006961) | Jerky head movements | 16049940 | IBIS | 3 / 7739 | ||
|
(HPO:0001771) | Achilles tendon contracture | 16049940 | IBIS | 27 / 7739 | ||
|
(HPO:0001239) | Wrist flexion contracture | 16049940 | IBIS | 13 / 7739 | ||
|
(HPO:0000252) | Microcephaly | 16049940 | IBIS | 832 / 7739 | ||
|
(HPO:0012751) | Abnormal basal ganglia MRI signal intensity | 16049940 | IBIS | 4 / 7739 | ||
|
(HPO:0002453) | Abnormality of the globus pallidus | 16049940 | IBIS | 4 / 7739 | ||
|
(MedDRA:10047920) | Wheelchair user | 16049940 | IBIS | 3 / 7739 | ||
|
(OMIM) | Decreased activity of the E2 subunit (lipoyl transacetylase, 608770) of the PDH | 16049940 | IBIS | 1 / 7739 | ||
|
(OMIM) | Decreased levels of the E2 subunit protein | 16049940 | IBIS | 1 / 7739 |
Associated genes:
DLAT; |
ClinVar (via SNiPA)
Gene symbol | Variation | Clinical significance | Reference |
---|
Additional Information:
Clinical Description OMIM |
Robinson et al. (1990) described a black infant who presented at 2 weeks of age with hyperammonemia and profound lactic acidosis. Control of blood lactates was achieved by carbohydrate restriction and bicarbonate supplementation, but at age 3.5 years ... |
Molecular genetics OMIM | In 2 unrelated patients with pyruvate dehydrogenase E2 deficiency, Head et al. (2005) identified 2 different homozygous mutations in the DLAT gene (608770.0001 and 608770.0002). |